Hims & Hers Health (HIMS) Short-term Investments (2020 - 2026)
Hims & Hers Health (HIMS) posted Short-term Investments of $528.6 million for Q1 2026, up 51.52% sequentially from $348.9 million in Q4 2025, and up 980.23% YoY from $48.9 million in Q1 2025.
Hims & Hers Health (HIMS) Short-term Investments (2020 - 2026) Analysis & Trends
Hims & Hers Health has reported Short-term Investments for 7 years, with the latest figure at $528.6 million in Q1 2026.
- Quarterly Short-term Investments rose 980.23% year-over-year to $528.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $528.6 million (up 980.23% YoY) and the FY2025 annual result came in at $348.9 million, up 337.92% from the prior year.
- Short-term Investments grew to $528.6 million in Q1 2026 per HIMS's latest filing, from $348.9 million in the prior quarter.
- Over five years, Short-term Investments peaked at $528.6 million in Q1 2026 and troughed at $20.0 million in Q2 2025.
- A 5-year average of $159.1 million and a median of $132.9 million in 2022 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2025 and 2026: Short-term Investments sank 79.56% in 2025, then surged 980.23% in 2026.
- Over 5 years, Short-term Investments stood at $132.9 million in 2022, then retreated by 6.42% to $124.3 million in 2023, then tumbled by 35.92% to $79.7 million in 2024, then jumped by 337.92% to $348.9 million in 2025, then surged by 51.52% to $528.6 million in 2026.
- According to Business Quant data, Short-term Investments over the past three periods registered $528.6 million, $348.9 million, and $284.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 231.24 Mn |
| Mar 31, 2026 | 528.61 Mn |
| Dec 31, 2025 | 348.88 Mn |
| Sep 30, 2025 | 283.97 Mn |
| Jun 30, 2025 | 20.03 Mn |
| Mar 31, 2025 | 48.94 Mn |
| Dec 31, 2024 | 79.67 Mn |
| Sep 30, 2024 | 88.55 Mn |
| Jun 30, 2024 | 98.00 Mn |
| Mar 31, 2024 | 98.36 Mn |
| Dec 31, 2023 | 124.32 Mn |
| Sep 30, 2023 | 154.50 Mn |
| Jun 30, 2023 | 127.73 Mn |
| Mar 31, 2023 | 135.65 Mn |
| Dec 31, 2022 | 132.85 Mn |
| Sep 30, 2022 | 140.43 Mn |
| Jun 30, 2022 | 139.94 Mn |
| Mar 31, 2022 | 154.77 Mn |
| Dec 31, 2021 | 175.49 Mn |
| Sep 30, 2021 | 187.65 Mn |